Novo Nordisk A/S (NVO)

Last Closing Price: 62.62 (2025-04-28)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Novo Nordisk A/S (NVO) had Net Income of $4.03B for the most recently reported fiscal quarter, ending 2024-12-31.

Figures for fiscal quarter ending 2024-12-31
Income Statement Financials
$12.26B
Net Income
$4.03B
$1.86B
$10.40B
$7.02B
$5.24B
$-172.91M
$5.07B
$5.07B
$4.03B
$4.03B
$4.03B
$4.03B
$5.24B
$5.97B
4.45B
4.46B
$0.90
$0.90
Balance Sheet Financials
$23.33B
$23.56B
$44.21B
$67.54B
$31.54B
$13.00B
$15.19B
$46.73B
$20.81B
$4.70B
$20.81B
4.46B
Cash Flow Statement Financials
$17.54B
$-18.69B
$1.27B
$2.09B
$2.27B
$183.13M
$331.90M
$-6.40B
--
Fundamental Metrics & Ratios
0.74
--
--
0.38
0.72
84.81%
42.77%
42.77%
--
41.36%
32.84%
$10.70B
--
--
--
0.18
0.31
0.97
93.04
19.35%
85.72%
5.96%
11.91%
$4.66
$2.40
$3.93